Regeneron Pharmaceuticals, Inc. (BIT:1REGN)

Regeneron Pharmaceuticals Statistics

Total Valuation

BIT:1REGN has a market cap or net worth of EUR 67.37 billion. The enterprise value is 54.38 billion.

Market Cap	67.37B
Enterprise Value	54.38B

Important Dates

The last earnings date was Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	Nov 19, 2025

Share Statistics

Current Share Class	100.80M
Shares Outstanding	n/a
Shares Change (YoY)	-5.65%
Shares Change (QoQ)	+0.28%
Owned by Insiders (%)	3.79%
Owned by Institutions (%)	87.98%
Float	98.54M

Valuation Ratios

The trailing PE ratio is 17.56 and the forward PE ratio is 16.15.

PE Ratio	17.56
Forward PE	16.15
PS Ratio	5.52
PB Ratio	2.53
P/TBV Ratio	2.64
P/FCF Ratio	19.39
P/OCF Ratio	15.89
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.07, with an EV/FCF ratio of 15.65.

EV / Earnings	14.17
EV / Sales	4.50
EV / EBITDA	15.07
EV / EBIT	17.43
EV / FCF	15.65

Financial Position

The company has a current ratio of 4.13, with a Debt / Equity ratio of 0.11.

Current Ratio	4.13
Quick Ratio	3.28
Debt / Equity	0.11
Debt / EBITDA	0.81
Debt / FCF	0.85
Interest Coverage	84.52

Financial Efficiency

Return on equity (ROE) is 14.87% and return on invested capital (ROIC) is 12.42%.

Return on Equity (ROE)	14.87%
Return on Assets (ROA)	5.91%
Return on Invested Capital (ROIC)	12.42%
Return on Capital Employed (ROCE)	10.23%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	792,722
Profits Per Employee	248,983
Employee Count	15,222
Asset Turnover	0.37
Inventory Turnover	2.53

Taxes

In the past 12 months, BIT:1REGN has paid 618.16 million in taxes.

Income Tax	618.16M
Effective Tax Rate	13.88%

Stock Price Statistics

The stock price has decreased by -6.74% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-6.74%
50-Day Moving Average	646.06
200-Day Moving Average	536.94
Relative Strength Index (RSI)	52.72
Average Volume (20 Days)	9

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.27

Income Statement

In the last 12 months, BIT:1REGN had revenue of EUR 12.22 billion and earned 3.84 billion in profits. Earnings per share was 35.33.

Revenue	12.22B
Gross Profit	5.44B
Operating Income	3.15B
Pretax Income	4.45B
Net Income	3.84B
EBITDA	3.62B
EBIT	3.15B
Earnings Per Share (EPS)	35.33

Balance Sheet

The company has 7.33 billion in cash and 2.94 billion in debt, with a net cash position of 13.13 billion.

Cash & Cash Equivalents	7.33B
Total Debt	2.94B
Net Cash	13.13B
Net Cash Per Share	n/a
Equity (Book Value)	26.62B
Book Value Per Share	259.47
Working Capital	11.63B

Cash Flow

In the last 12 months, operating cash flow was 4.24 billion and capital expenditures -765.17 million, giving a free cash flow of 3.48 billion.

Operating Cash Flow	4.24B
Capital Expenditures	-765.17M
Free Cash Flow	3.48B
FCF Per Share	n/a

Margins

Gross margin is 44.57%, with operating and profit margins of 25.81% and 31.41%.

Gross Margin	44.57%
Operating Margin	25.81%
Pretax Margin	36.47%
Profit Margin	31.41%
EBITDA Margin	29.60%
EBIT Margin	25.81%
FCF Margin	28.45%

Dividends & Yields

This stock pays an annual dividend of 3.14, which amounts to a dividend yield of 0.48%.

Dividend Per Share	3.14
Dividend Yield	0.48%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	8.22%
Buyback Yield	5.65%
Shareholder Yield	6.13%
Earnings Yield	5.70%
FCF Yield	5.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIT:1REGN has an Altman Z-Score of 6.51 and a Piotroski F-Score of 4.

Altman Z-Score	6.51
Piotroski F-Score	4